Did cough syrup export cause 20 deaths in MP? WHO asks India for clarification

The government has been asked by the World Health Organization (WHO) to clarify whether the Coldrif cough syrup, which was implicated in the deaths of 20 children in Madhya Pradesh, has been exported to other nations. The WHO stated that upon formal confirmation from Indian authorities, it will evaluate whether a Global Medical Products Alert is necessary for Coldrif syrup.

According to state health minister Rajendra Shukla, kidney infections brought on by the consumption of the tainted cough syrup have resulted in the deaths of 20 children in Madhya Pradesh thus far and the critical admission of five more. To look into the fatalities, a seven-member SIT has been established. According to sources who spoke to PTI, the SIT, headed by an Assistant Commissioner of Police, investigated the drug manufacturer's factory outside of Chennai on Wednesday.

'Coldrif' cough syrup is supplied to Puducherry, Madhya Pradesh, Rajasthan, and other states by a pharmaceutical company based in Chennai. It has been announced by the Food Safety and Drug Administration department that the cough syrup samples that were taken from the Sunguvarchatram, Kancheepuram, manufacturing plant were 'adulterated'. The business has been told to 'stop manufacturing' right away. The "contaminated" cough syrups are already prohibited in states including Tamil Nadu, Punjab, and Telangana.